Dendreon
Dendreon, based in Union City, GA, is a pioneering leader in cellular technology, revolutionizing medicine through innovative science and cellular therapies. With a singular focus on improving patients' lives, Dendreon drives the future of complex cell therapies through research, development, and strategic partnerships.
The company's flagship innovation, PROVENGE sipuleucel-T, was the first FDA-approved cellular immunotherapy on the market, benefiting nearly 40,000 men. Dendreon also offers expertise in Cellular Therapy Manufacturing, supporting companies in bringing life-saving innovations to market through their experience, knowledge, and logistical capabilities.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.